Hsa_circ_0041150 serves as a novel biomarker for monitoring chemotherapy resistance in small cell lung cancer patients treated with a first-line chemotherapy regimen

PURPOSE: To explore the potential of circRNAs as biomarkers in non-invasive body fluids for monitoring chemotherapy resistance in SCLC patients. METHODS: CircRNAs were screened and characterized using transcriptome sequencing, Sanger sequencing, actinomycin D treatment, and Ribonuclease R assay. Our...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhang, Yang, Chao, Fengmei, Lv, Lihua, Li, Ming, Shen, Zuojun
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Berlin Heidelberg 2023
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10620281/
https://www.ncbi.nlm.nih.gov/pubmed/37639013
http://dx.doi.org/10.1007/s00432-023-05317-6

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10620281/
https://www.ncbi.nlm.nih.gov/pubmed/37639013
http://dx.doi.org/10.1007/s00432-023-05317-6

Ejemplares similares